Home » Topics » Disease categories and therapies » Immune

Immune
RSS

European approval for Rotarix

Feb. 28, 2006

In vitro activity of new immunomodulator FQPD in multiple myeloma

Feb. 24, 2006

ACIP recommends addition of RotaTeq to childhood immunization schedule

Feb. 24, 2006

Kyorin signs license agreement with Novartis for immunomodulator KRP-203

Feb. 22, 2006

Novavax enters research collaboration with U. of Pittsburgh

Feb. 17, 2006

Avant's typhoid fever vaccine Ty-800 studied in new phase I/II trial

Feb. 16, 2006

New phase I/II study assesses sublingual vaccines with MPL adjuvant for allergy

Feb. 15, 2006

DOR preparing regulatory submissions for orBec in iGVHD

Feb. 13, 2006

RotaTeq receives FDA approval

Feb. 7, 2006

New agents for immunological disorders imparted in recent Taisho patent

Feb. 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...